Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study

ConclusionsExenatide and liraglutide resulted in similar glycaemic effects (HbA1C and fasting plasma glucose changes) in patients with type 2 diabetes who were sub ‐optimally controlled with other anti‐diabetic therapy. However, this study supports the effectiveness of both medications for weight reduction at both endpoints. A prospective large‐scale study is recommended to overcome the study limitations.

Source: Journal of Pharmaceutical Health Services Research - June 22, 2018 Category: Drugs & Pharmacology Authors: Zainab Jassim, Reem Elajez, Imran Khudair, Rasha Al Anany, Rana Moustafa Al ‐Adawi Tags: Research Paper Source Type: research